Looking Into the Future of Lipid Management
Dr Taub, Dr Patel, and Dr Kohli look ahead to the future of the management of cardiovascular risk and hyperlipidemia
Read More
How to Select Between Available LDL-C Lowering Therapies
Cardiologists discuss how to select the right treatment for your patient with hyperlipidemia
Clinical Trial Results on Novel Nonstatins Agents.
Expert cardiologists discuss the recent clinical trials results of the CLEAR-OUTCOMES trial and thee sub analysis on the inflammatory marker hcCRP.
Mechanism of Action of Nonstatin Therapies
Dr Kohli gives an overview of the mechanisms of action of non-statin agents for the management of hyperlipidemia.
The Cumulative Burden of LDL-C
Expert cardiologists discuss the cumulative burden of an elevated cholesterol over time.
Overcoming Access Barriers to Novel Non Statin Therapies
Dr Taub describes effective strategies in overcoming access barriers to novel lipid lowering therapies.
Combination Therapy in LDL Lowering
Expert cardiologists describe the importance of combination therapy for hyperlipidemia in high risk patients
Nonstatin Agents for LDL-C Lowering
Dr Taub and Dr Patel discuss which non statin agents are available for LDL-C lowering.
How Low is Too Low in LDL-C?
Expert cardiologists discuss if there is such a thing as an LDL that is a too low.
Matching the Intensity of Treatment to Cardiovascular Risk
Dr Taub discusses how to match the intensity of lipid lowering therapy to the assessed cardiovascular risk.
Assessing Cardiovascular Risk in Your Patients
Dr Taub and Dr Patel discuss how to assess for cardiovascular risk in your patients.
Resources for Sleep Disorders
Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.
Unmet Needs in Sleep Disorder Management
Nathaniel F. Watson, MD, leads a discussion on gaps in care and unmet needs for patients and healthcare professionals in the area of sleep disorders.
Emerging Treatment Options for Sleep Disorders
Experts in sleep medicine share emerging treatments in the pipeline for the management of sleep disorders.
Treatment Adherence in Sleep Disorders
Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson examine setting treatment expectations with patients and treatment adherence for sleep disorders.
Selecting Specific DORAs for Insomnia
Ashgan A. Elshinawy, DO, shares her approach to treatment selection of DORAs and switching therapies for the management of sleep disorders.
Phase 3 Studies With Daridorexant for Insomnia Management
Nathaniel F. Watson, MD, highlights the use of daridorexant for treating patients with insomnia as seen from phase 3 trials and data presented at the World Sleep 2022 meeting and managing adverse events.
FDA-Approved Therapies for the Management of Sleep Disorders
Drs Ashgan A. Elshinawy, C. Michael Gibson, and Nathaniel F. Watson discuss FDA-approved medications currently used for the treatment of sleep disorders and insomnia, and comment on the difference between DORAs.
Sleep Disorders: Sleep and Wakefulness Pathways
Nathaniel F. Watson, MD, reviews the pathways involved in sleep and wakefulness cycles as it relates to sleep disorders.
Treatment Selection for Sleep Disorders
Dr Ashgan A. Elshinawy and C. Michael Gibson considers safety and efficacy factors when approaching treatment selection for sleep disorders and insomnia.
Role of Patient Communication in Sleep Disorder Management
Ashgan A. Elshinawy, DO, comments on engaging patients in conversations around managing sleep disorders with co-occurring health conditions.
Approaching Diagnosis and Treatment of Sleep Disorders and Co-occurring Health Conditions
Experts in sleep medicine stress the importance of early diagnosis of sleep disorders and how they approach treatment in their clinics.
Screening for Sleep Disorders
Dr Nathaniel F. Watson reviews screening patients for sleep disorders and referral to sleep specialists.
Complications of Sleep Disorders and Impact on Quality of Life
Nathaniel F. Watson, MD; Ashgan A. Elshinawy, DO; and C. Michael Gibson, MD, examine complications patients encounter with sleep disorders, including for insomnia, and the impact on their quality of life.
Co-occurrence of Sleep Disorders With Other Health Conditions
Ashgan A. Elshinawy, DO, leads a discussion on the co-occurrence and relationship between sleep disorders and different health conditions in patients.
Overview of Sleep Disorders
Dr Nathaniel F. Watson, MD, provides insight on the prevalence of various sleep disorders, including insomnia, and patient populations at high-risk for developing these disorders.